• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于光热治疗的聚集型、具有表面增强拉曼散射活性的超小金纳米粒子

Clustered, SERS-Active, Ultrasmall AuNPs for Photothermal Therapy.

作者信息

Mellor Ryan D, Xiong Guojun, Vaideanu Alexandra G, Gardner Benjamin, Stone Nick, Schätzlein Andreas G, Uchegbu Ijeoma F

机构信息

School of Pharmacy, University College London (UCL), London, WC1N 1AX, UK.

School of Physics and Astronomy, University of Exeter, Exeter, EX4 4QL, UK.

出版信息

Int J Nanomedicine. 2025 Jun 25;20:8209-8220. doi: 10.2147/IJN.S513400. eCollection 2025.

DOI:10.2147/IJN.S513400
PMID:40584787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12206418/
Abstract

INTRODUCTION

Gold nanoclusters (AuNCs) have emerged as promising agents for photothermal cancer therapy due to their unique optical properties and potential for tumour targeting.

METHODS

In this study, we developed clustered, excretable AuNCs using a glycol chitosan derivative (GCPQ) and investigated their physicochemical properties, photothermal effect, and therapeutic efficacy.

RESULTS

The AuNCs exhibited tunable surface plasmon resonance peaks dependent on the polymer:AuNP ratio, with optimized clusters showing surface enhanced Raman scattering and photothermal heating. In vivo studies in a mouse tumour model demonstrated significant tumour growth inhibition (334% growth vs 607% growth for untreated animals after 6 days) when combining intratumoural AuNC injection with near-infrared laser irradiation.

CONCLUSION

The results provide proof-of-concept for the potential of these AuNCs in photothermal cancer therapy. Future work should focus on improving tumour targeting, optimizing treatment parameters, and assessing long-term safety to advance this platform toward clinical translation.

摘要

引言

金纳米团簇(AuNCs)因其独特的光学性质和肿瘤靶向潜力,已成为光热癌症治疗中颇具前景的药物。

方法

在本研究中,我们使用一种壳聚糖二醇衍生物(GCPQ)制备了可聚集、可排泄的金纳米团簇,并研究了它们的物理化学性质、光热效应和治疗效果。

结果

金纳米团簇表现出取决于聚合物与金纳米粒子比例的可调表面等离子体共振峰,优化后的团簇显示出表面增强拉曼散射和光热加热。在小鼠肿瘤模型中的体内研究表明,当瘤内注射金纳米团簇并结合近红外激光照射时,肿瘤生长受到显著抑制(6天后,治疗组肿瘤生长334%,未治疗动物为607%)。

结论

这些结果为这些金纳米团簇在光热癌症治疗中的潜力提供了概念验证。未来的工作应集中在改善肿瘤靶向性、优化治疗参数以及评估长期安全性,以推动该平台向临床转化发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/77f3c929f419/IJN-20-8209-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/9b10f3921ec9/IJN-20-8209-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/065c9fa913bb/IJN-20-8209-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/c5b7c17d187e/IJN-20-8209-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/dc28701c0b77/IJN-20-8209-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/25e361b6f1ec/IJN-20-8209-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/4d0a9e61f5d0/IJN-20-8209-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/de83aec70773/IJN-20-8209-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/77f3c929f419/IJN-20-8209-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/9b10f3921ec9/IJN-20-8209-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/065c9fa913bb/IJN-20-8209-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/c5b7c17d187e/IJN-20-8209-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/dc28701c0b77/IJN-20-8209-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/25e361b6f1ec/IJN-20-8209-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/4d0a9e61f5d0/IJN-20-8209-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/de83aec70773/IJN-20-8209-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f528/12206418/77f3c929f419/IJN-20-8209-g0008.jpg

相似文献

1
Clustered, SERS-Active, Ultrasmall AuNPs for Photothermal Therapy.用于光热治疗的聚集型、具有表面增强拉曼散射活性的超小金纳米粒子
Int J Nanomedicine. 2025 Jun 25;20:8209-8220. doi: 10.2147/IJN.S513400. eCollection 2025.
2
Hybrid Nanocarrier Delivers Immuno-Photothermal Therapy to Modulate Pancreatic Tumor Microenvironment.混合纳米载体实现免疫光热疗法以调节胰腺肿瘤微环境。
ACS Appl Bio Mater. 2025 Jun 16;8(6):5239-5251. doi: 10.1021/acsabm.5c00562. Epub 2025 May 20.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Recent advances in the design of SERS substrates and sensing systems for (bio)sensing applications: Systems from single cell to single molecule detection.用于(生物)传感应用的表面增强拉曼散射(SERS)基底和传感系统设计的最新进展:从单细胞检测到单分子检测的系统
F1000Res. 2025 Mar 18;13:670. doi: 10.12688/f1000research.149263.2. eCollection 2024.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
GRPR-targeted gold nanoparticles as selective radiotherapy enhancers in glioblastoma.靶向胃泌素释放肽受体的金纳米颗粒作为胶质母细胞瘤的选择性放疗增强剂
Phys Med Biol. 2025 Jun 20;70(12). doi: 10.1088/1361-6560/ade222.
8
MoS-Based nanocomposite for synergistic chemo-photothermal cancer therapy.用于协同化学-光热癌症治疗的基于二硫化钼的纳米复合材料。
Sci Rep. 2025 Jul 2;15(1):22788. doi: 10.1038/s41598-025-05615-8.
9
A switch-on chemo-photothermal nanotherapy impairs glioblastoma.一种开启式化学光热纳米疗法可损害胶质母细胞瘤。
Mater Horiz. 2025 Jun 30;12(13):4771-4787. doi: 10.1039/d5mh00351b.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents-A Novel Polymer Formulation for Anticancer Therapy.负载铂类抗癌药物的季铵化棕榈酰甘醇壳聚糖(GCPQ)——一种用于抗癌治疗的新型聚合物制剂
Pharmaceuticals (Basel). 2023 Jul 19;16(7):1027. doi: 10.3390/ph16071027.
2
Ultrasmall-in-Nano: Why Size Matters.纳米中的超小尺寸:为何尺寸至关重要。
Nanomaterials (Basel). 2022 Jul 19;12(14):2476. doi: 10.3390/nano12142476.
3
Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters.
生物功能化、拉曼响应且可能可排泄的金纳米团簇的开发。
Nanomaterials (Basel). 2021 Aug 25;11(9):2181. doi: 10.3390/nano11092181.
4
Smart Gold Nanostructures for Light Mediated Cancer Theranostics: Combining Optical Diagnostics with Photothermal Therapy.用于光介导癌症诊疗的智能金纳米结构:将光学诊断与光热疗法相结合
Adv Sci (Weinh). 2020 Jun 18;7(15):1903441. doi: 10.1002/advs.201903441. eCollection 2020 Aug.
5
Direct monitoring of light mediated hyperthermia induced within mammalian tissues using surface enhanced spatially offset Raman spectroscopy (T-SESORS).利用表面增强空间偏移拉曼光谱(T-SESORS)直接监测哺乳动物组织中光介导的热疗。
Analyst. 2019 May 28;144(11):3552-3555. doi: 10.1039/c8an02466a.
6
Gold Nanoparticles for Photothermal Cancer Therapy.用于光热癌症治疗的金纳米颗粒。
Front Chem. 2019 Apr 5;7:167. doi: 10.3389/fchem.2019.00167. eCollection 2019.
7
Development of forced degradation and stability indicating studies of drugs-A review.药物强制降解及稳定性指示研究的进展——综述
J Pharm Anal. 2014 Jun;4(3):159-165. doi: 10.1016/j.jpha.2013.09.003. Epub 2013 Sep 17.
8
The mouse thermoregulatory system: Its impact on translating biomedical data to humans.小鼠体温调节系统:其对将生物医学数据转化应用于人类的影响。
Physiol Behav. 2017 Oct 1;179:55-66. doi: 10.1016/j.physbeh.2017.05.026. Epub 2017 May 19.
9
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?金纳米诊疗学:概念验证还是临床工具?
Nanomaterials (Basel). 2015 Nov 3;5(4):1853-1879. doi: 10.3390/nano5041853.
10
Theranostic Gold Nanomicelles made from Biocompatible Comb-like Polymers for Thermochemotherapy and Multifunctional Imaging with Rapid Clearance.基于生物相容梳状聚合物的诊疗一体化金纳米胶束用于热化疗和多功能成像并具有快速清除特性。
Adv Mater. 2015 Jun 24;27(24):3645-53. doi: 10.1002/adma.201501420. Epub 2015 May 6.